Immtech has alliances with a group of talented and dedicated scientists who have spent their careers in pursuit of cures for infectious diseases.
Immtech Pharmaceuticals has an alliance with a consortium of universities and research
institute laboratories. This gives us access to accomplished scientists and development
teams whose members contribute to the discovery and development of compounds in our
medicinal chemistry library.
Two of our most widely published and respected lead scientists, Dr. Richard Tidwell and
Dr. David Boykin, have attracted a cadre of other renowned scientists to the consortium.
Together, they offer a depth of research knowledge and capabilities rivaled only by large,
multifaceted pharmaceutical companies.
Our scientists include:
Richard R. Tidwell, PhD
Head of Research
Director of the Research Consortium,
Chairman of the Scientific Advisory Board
David W. Boykin, PhD
Regents’ Professor Emeritus of Chemistry,
Georgia State University
Dr. Boykin received his PhD in Organic Chemistry from the University of Virginia,
Charlottesville, VA. He served as Professor, and then Chairman for the
Department of Chemistry at Georgia State University, and as Co-Director of the
Laboratory for Microbial and Biochemical Sciences. In 1993, Dr. Boykin was made
Associate Dean for Natural Sciences at Georgia State University and was
established as a Regents' Professor. He has served as Editor for North America
for Heterocyclic Communications. Dr. Boykin's research focuses on two areas:
drug design and synthesis, and applications of 170 NMR spectroscopy to organic
chemistry. His drug design and synthesis work centers on development of
molecules, primarily heterocyclics, which selectively interact with nucleic acids.
Byron L. Blagburn, PhD
Department of Pathobiology
Christine C. Dykstra, PhD
Auburn University, College of Veterinary Medicine
Scott M. Franzblau, PhD
University of Illinois at Chicago
James E. Hall, PhD
UNC-CH School of Medicine
© 2008 Immtech. All Rights Reserved